Early wins in planning, monitoring, and training meet real‑world risks, a new review finds.
Artificial intelligence (AI) is rapidly moving from the lab to the operating room in breast reconstruction, with tools that can help surgeons plan procedures, guide delicate microsurgery, and watch for complications after the operation. A new narrative review pulls together the state of the science—and its blind spots—so patients and clinicians can understand what’s coming next.
What’s working now
Researchers report promising results across the care pathway. AI has boosted pre‑op imaging to map anatomy for reconstruction, supported intra‑operative precision, predicted risks like flap failure, and streamlined post‑op monitoring for blood‑flow problems that threaten grafts. In a roundup of early studies, a machine‑learning model flagged obesity, smoking, and timing as major risk factors for flap loss; a smart monitoring system improved perfusion checks; and a neural network accurately previewed likely cosmetic results before surgery. Another tool cut pre‑op vessel‑mapping time by about two hours per patient. (See Table 3 on page 7 for the study snapshots.)
AI is also changing how surgeons learn and how research gets done. Augmented‑reality headsets are already being used in surgical training programs (including at Stanford), while large language models and machine learning can sift big patient datasets to spot patterns that inform decisions and studies. (Section 2.5 and Table 2 on page 6 describe these training and research gains, and outline potential advantages of AI—better accuracy, shorter cases, and more predictable cosmetic results.)
Why it matters for patients
If validated and used safely, these tools could mean fewer re‑operations, shorter surgeries, and higher satisfaction with symmetry and appearance—benefits patients can feel. Although some AI systems may be costly up front, the review notes they could lower overall costs by preventing complications and additional procedures. (Table 2, page 6).
The fine print: real risks and open questions
The authors stress that AI is not a replacement for surgical judgment. Errors from biased or unbalanced training data could misidentify critical anatomy; latency in remote or telerobotic systems might delay responses; and cyber‑security or software failures in the operating room could cause harm. The paper calls for rigorous clinical trials, continuous human oversight, and transparent algorithms. It also flags ethical and legal issues—privacy, consent, and who is responsible if an AI‑assisted step goes wrong—as well as concerns about workforce disruption if automation outpaces training.
Bottom line AI is poised to reshape breast reconstruction—from planning through recovery—but it needs sturdy guardrails. Patients considering reconstruction can ask their teams whether any AI‑enabled planning or monitoring is being used, how it’s validated, and how surgeons supervise it. As the review concludes, careful integration—not hype—is the path to safer, more personalized care.
Source: Rugină AI, Ungureanu A, Giuglea C, Marinescu SA. “Artificial Intelligence in Breast Reconstruction: A Narrative Review,” Medicina (2025). See Table 2 on p. 6 and Table 3 on p. 7 for practical examples and advantages.